{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T13:49:29Z","timestamp":1761918569706},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1007\/s00115-003-1618-y","type":"journal-article","created":{"date-parts":[[2004,3,18]],"date-time":"2004-03-18T21:58:25Z","timestamp":1079647105000},"page":"589-594","source":"Crossref","is-referenced-by-count":3,"title":["Autoimmune Funktionsst\u00f6rungen der Schilddr\u00fcse unter Interferon-\u03b2-1b-Therapie bei Patienten mit Multipler Sklerose","Thyroid autoimmunity disorders during interferon \u03b2-1b treatment in patients with multiple sclerosis: review and case report"],"prefix":"10.1007","volume":"75","author":[{"given":"C.","family":"Lange-Asschenfeldt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Boor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. J.","family":"Kahaly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Th\u00f6mke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"1618_CR1","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S0022-510X(99)00168-9","volume":"168","author":"Annunziata","year":"1999","unstructured":"Annunziata P, Lore F, Venturini E, Morana P, Guarino E, Borghi S, Guazzi GC (1999) Early synthesis and correlation of serum anti-thyroid antibodies with clinical parameters in multiple sclerosis. J Neurol Sci 168: 32\u201336","journal-title":"J Neurol Sci"},{"key":"1618_CR2","first-page":"1925","volume":"86","author":"Carella","year":"2001","unstructured":"Carella C, Mazziotti G, Morisco F, Manganella G, Rotondi M, Tuccillo C, Sorvillo F, Caporaso N, Amato G (2001) Long-term outcome of interferon-\u03b1-induced thyroid autoimmunity and prognostic influence of thyroid autoantibody pattern at the end of treatment. J Clin Endocrinol Metab 86: 1925\u20131929","journal-title":"J Clin Endocrinol Metab"},{"key":"1618_CR3","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S0022-510X(98)00299-8","volume":"162","author":"Durelli","year":"1999","unstructured":"Durelli L, Ferrero B, Oggero A, Verdun E, Bongioanni MR, Gentile E, Isoardo GL, Ricci A, Rota E, Bergamasco B, Durazzo M, Saracco G, Biava MA, Brossa PC, Giorda L, Pagni R, Aimo G (1999) Autoimmune events during interferon beta-1b treatment for multiple sclerosis. J Neurol Sci 162: 74\u201383","journal-title":"J Neurol Sci"},{"key":"1618_CR4","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1212\/WNL.57.8.1363","volume":"57","author":"Durelli","year":"2001","unstructured":"Durelli L, Ferrero B, Oggero A, Verdun E, Ghezzi A, Montanari E, Zaffaroni M (2001) Liver and thyroid function and autoimmunity during interferon-beta 1b treatment for MS. Neurology 57: 1363\u20131370","journal-title":"Neurology"},{"key":"1618_CR5","first-page":"3525","volume":"86","author":"Durelli","year":"2001","unstructured":"Durelli L, Ferrero B, Oggero A, Verdun E, Ghezzi A, Montanari E, Zaffaroni M (2001) Thyroid function and autoimmunity during interferon beta-1b treatment: a multicenter prospective study. J Clin Endocrinol Metab 86: 3525\u20133532","journal-title":"J Clin Endocrinol Metab"},{"key":"1618_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0022-510X(01)00637-2","volume":"193","author":"Durelli","year":"2001","unstructured":"Durelli L, Oggero A, Verdun E, Isoardo GL, Barbero P, Bergamasco B, Brossa PC, Ghigo E, Maccario M, Faggiano F (2001) Thyroid function and anti-thyroid antibodies in MS patients screened for interferon treatment. A multicenter study. J Neurol Sci 193: 17\u201322","journal-title":"J Neurol Sci"},{"key":"1618_CR7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1530\/eje.0.1450107","volume":"145","author":"Kahaly","year":"2001","unstructured":"Kahaly GJ (2001) Imaging in thyroid-associated orbitopathy. Eur J Endocrinol 145: 107\u2013118","journal-title":"Eur J Endocrinol"},{"key":"1618_CR8","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1212\/WNL.53.4.883","volume":"53","author":"Karni","year":"1999","unstructured":"Karni A, Abramsky O (1999) Association of MS with thyroid disorders. Neurology 53: 883\u2013885","journal-title":"Neurology"},{"key":"1618_CR9","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1034\/j.1600-0404.2003.02009.x","volume":"107","author":"Kreisler","year":"2003","unstructured":"Kreisler A, Seze J de, Stojkovic T, Delisse B, Combelles M, V\u00e9rier A, Hautecoeur P, Vermersch P (2003) Multiple sclerosis, interferon beta and clinical thyroid dysfunction. Acta Neurol Scand 107: 154\u2013157","journal-title":"Acta Neurol Scand"},{"key":"1618_CR10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF02427558","volume":"19","author":"Martinelli","year":"1998","unstructured":"Martinelli V, Gironi M, Rodegher M, Martino G, Comi G (1998) Occurrence of thyroid autoimmunity in relapsing remitting multiple sclerosis patients undergoing interferon-beta treatment. Ital J Neurol Sci 19: 65\u201367","journal-title":"Ital J Neurol Sci"},{"key":"1618_CR11","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1530\/eje.0.1410325","volume":"141","author":"Monzani","year":"1999","unstructured":"Monzani F, Caraccio N, Meucci G, Lombardo F, Moscato G, Casolaro A, Ferdeghini M, Murri L, Ferrannini E (1999) Effect of 1-year treatment with interferon-beta1b on thyroid function and autoimmunity in patients with multiple sclerosis. Eur J Endocrinol 141: 325\u2013331","journal-title":"Eur J Endocrinol"},{"key":"1618_CR12","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1212\/WNL.55.4.549","volume":"55","author":"Monzani","year":"2000","unstructured":"Monzani F, Caraccio N, Casolaro A, Lombardo F, Moscato G, Murri L, Ferrannini E, Meucci G (2000) Long-term interferon beta-1b therapy for MS: is routine thyroid assessment always useful? Neurology 55: 549\u2013552","journal-title":"Neurology"},{"key":"1618_CR13","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1089\/107999002320271369","volume":"22","author":"Monzani","year":"2002","unstructured":"Monzani F, Meucci G, Caraccio N, Saviozzi M, Casolaro A, Moscato G, Lombardo F, Mosti S, Scagnolari C, Bruschi F, Antonelli G, Ferrannini E, Murri L (2002) Discordant effect of IFN-beta1a therapy on anti-IFN antibodies and thyroid disease development in patients with multiple sclerosis. J Interferon Cytokine Res 22: 773\u2013781","journal-title":"J Interferon Cytokine Res"},{"key":"1618_CR14","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/s00415-003-1053-9","volume":"250","author":"Niederwieser","year":"2003","unstructured":"Niederwieser G, Buchinger W, Monelli RM, Berghold A, Reisecker F, Koltringer P, Archelos JJ (2003) Prevalence of autoimmune thyroiditis and non-immune thyroid disease in multiple sclerosis. J Neurol 250: 672\u2013675","journal-title":"J Neurol"},{"key":"1618_CR15","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/BF03348040","volume":"21","author":"Rotondi","year":"1998","unstructured":"Rotondi M, Oliviero A, Profice P, Mone CM, Biondi B, Del Buono A, Mazziotti G, Sinisi AM, Bellastella A, Carella C (1998) Occurrence of thyroid autoimmunity and dysfunction throughout a nine-month follow-up in patients undergoing interferon-beta therapy for multiple sclerosis. J Endocrinol Invest 21: 748\u2013752","journal-title":"J Endocrinol Invest"},{"key":"1618_CR16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/BF03343730","volume":"23","author":"Rotondi","year":"2000","unstructured":"Rotondi M, Mazziotti G, Biondi B, Manganella G, Del Buono AD, Montella P, Cristofaro M di, Di Iorio G, Amato G, Carella C (2000) Long-term treatment with interferon-beta therapy for multiple sclerosis and occurrence of Graves\u2018 disease. J Endocrinol Invest 23: 321\u2013324","journal-title":"J Endocrinol Invest"},{"key":"1618_CR17","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1001\/archneur.1997.00550210095020","volume":"54","author":"Schwid","year":"1997","unstructured":"Schwid SR, Goodman AD, Mattson DH (1997) Autoimmune hyperthyroidism in patients with multiple sclerosis treated with interferon beta-1b. Arch Neurol 54: 1169\u20131190","journal-title":"Arch Neurol"},{"key":"1618_CR18","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1001\/jama.263.11.1529","volume":"263","author":"Surks","year":"1990","unstructured":"Surks MI, Chopra IJ, Mariash CN, Nicoloff JT, Solomon DH (1990) American Thyroid Association guidelines for use of laboratory tests in thyroid disorders. JAMA 263: 1529\u20131532","journal-title":"JAMA"},{"key":"1618_CR19","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1001\/archneur.55.4.517","volume":"55","author":"Tourbah","year":"1998","unstructured":"Tourbah A, Clapin A, Gout O, Fontaine B, Liblau R, Batteux F, Stievenart JL, Weill B, Lubetzki C, Lyon-Caen O (1998) Systemic autoimmune features and multiple sclerosis: a 5-year follow-up study. Arch Neurol 55: 517\u2013521","journal-title":"Arch Neurol"},{"key":"1618_CR20","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1089\/107999002753536220","volume":"22","author":"Verdun","year":"2002","unstructured":"Verdun E, Isoardo G, Oggero A, Ferrero B, Ghezzi A, Montanari E, Zaffaroni M, Durelli L (2002) Autoantibodies in multiple sclerosis patients before and during IFN-beta 1b treatment: are they correlated with the occurrence of autoimmune diseases? J Interferon Cytokine Res 22: 245\u2013255","journal-title":"J Interferon Cytokine Res"},{"key":"1618_CR21","first-page":"788","volume":"15","author":"Weetman","year":"1994","unstructured":"Weetman AP, McGregor AM (1994) Autoimmune thyroid disease: further developments in our understanding. Endocr Rev 15: 788\u2013830","journal-title":"Endocr Rev"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-003-1618-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00115-003-1618-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-003-1618-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-003-1618-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T09:12:01Z","timestamp":1699348321000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00115-003-1618-y"}},"subtitle":["Kasuistik und Literatur\u00fcbersicht"],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["1618"],"URL":"https:\/\/doi.org\/10.1007\/s00115-003-1618-y","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}